TIGIT disruption rescues the antitumor activity of low avidity TCR-engineered T cells by increasing TCR signal strength

Journal:

Nature Communications

Published:

2026-01-08

DOI:

10.1038/s41467-025-67263-w

Affiliations:

14

Authors:

38

Go to article

Institutions	Authors	Share
San Raffaele Scientific Institute, Italy	26.666667 26.666667 26.666667	0.70
Vita-Salute San Raffaele University (UniSR), Italy	5.833333	0.15
San Raffaele Telethon Institute for Gene Therapy (HSR-TIGET), Italy	3.500000	0.09
TUM University Hospital Klinikum rechts der Isar (MRI), Germany	2.000000	0.05

Interested in Immunology?